- NEW ANALOGS AS ANDROGEN RECEPTOR AND GLUCOCORTICOID RECEPTOR MODULATORS
-
The present invention relates to novel dihydropyridine derivatives of formula (I): as modulators of nuclear receptors selected from androgen receptor and glucocorticoid receptor, to processes for their preparation, to pharmaceutical compositions comprising said compounds and to the use of said for manufacturing a medicament for the treatment of pathological conditions or diseases that can improve by modulation of androgen receptor and/or glucocorticoid receptor, selected from cancer, metastasizing cancers, benign prostate hyperplasia, polycystic ovary syndrome (PCOS), hair loss, hirsutism, acne, hypogonadism, muscle wasting diseases, cachexia, Cushing's syndrome, anti-psychotic drug induced weight gain, obesity, post-traumatic stress disorder and alcoholism.
- -
-
Paragraph 0289; 0290; 0291; 0293; 0294
(2019/05/16)
-
- Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors
-
New modifications to the scaffold of previously reported HBV capsid assembly effectors such as BAY 41-4109, HAP-12 and GLS4 were explored. The anti-HBV activity in the HepAD38 system, and cytotoxicity profiles of each of the new compounds has been assessed. Among them, five new iodo- and bromo-heteroarylpyrimidines analogs displayed anti-HBV activity in the low micromolar range.
- Boucle, Sebastien,Lu, Xiao,Bassit, Leda,Ozturk, Tugba,Russell, Olivia Ollinger,Amblard, Franck,Coats, Steven J.,Schinazi, Raymond F.
-
p. 904 - 910
(2017/02/10)
-
- New variant of the Pfizinger reaction. Synthesis and chemical transformations of substituted 2-aminomethyl-quinoline-3,4-dicarboxylic acids
-
We present a convenient synthesis of novel 8-sulfonyl-4-(morpholin-4-ium-4- ylmethyl)-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines using a modification of the classical Pfitzinger reaction. According to our method, the 5-sulfonylated isatins were reacted with a mixture of ethyl 4-chloro-3- oxobutanoate and morpholine. The resulting quinoline-3,4-dicarboxylic acids were then successively converted into the corresponding furo[3,4-c]quinoline-1,3- diones and pyrrolo[3,4-c]quinoline-1,3-diones. The latters appeared to be effective nonpeptide inhibitors of caspase-3 enzyme.
- Kravchenko, Dmitri V.,Kysil, Volodymyr M.,Tkachenko, Sergey E.,Maliarchouk, Sergey,Okun, Ilya M.,Ivachtchenko, Alexandre V.
-
-
- Medicaments against viral diseases
-
Novel dihydropyrimidines and combinations thereof with other antiviral agents, suitable for combating HBV infections.
- -
-
-